Author | Jun Gong, MD | OncLive

Author | Jun Gong, MD

Articles

Dr. Gong on Adverse Events of TKI VEGF-Directed Therapy in RCC

February 02, 2017

Video

Jun Gong, MD, fellow, City of Hope, discusses adverse events (AEs) associated with TKI/VEGF-directed therapy for patients with metastatic renal cell carcinoma (RCC).

x